Andy Herbert
Board of director
Healthcare
NZBIO
New Zealand
Biography
Andy Herbert started work in the biotechnology industry in 1984. After receiving a doctorate in biochemical engineering sponsored by Unilever in the UK, he worked for five years in process development in ICI’s industrial fermentation and biochemicals division. He moved to Canada in 1989 and spent nine years in human vaccine development with Sanofi-Pasteur, ultimately taking responsibility for all vaccine development at the company. He was part of teams that developed and licensed the world’s most effective acellular pertussis vaccine and the world’s first human cancer vaccine (ImmuCyst®, for the treatment of superficial bladder cancer). In 1998 he founded a biopharmaceutical engineering consulting company in Toronto and over the next eight years assisted mo
Research Interest
Healthcare
